UnitedHealth Stock Is Having Its Worst Year Since 2008. Can It Recover?
Investment
The Motley Fool

UnitedHealth Stock Is Having Its Worst Year Since 2008. Can It Recover?

July 28, 2025
08:14 PM
4 min read
AI Enhanced
investmenteconomytradingfinancialhealthcaremarket cyclesseasonal analysismarket

Key Takeaways

The healthcare giant's value has been in free fall this year as bad news continues to pile up.

Article Overview

Quick insights and key information

Reading Time

4 min read

Estimated completion

Category

investment

Article classification

Published

July 28, 2025

08:14 PM

Source

The Motley Fool

Original publisher

Key Topics
investmenteconomytradingfinancialhealthcaremarket cyclesseasonal analysismarket

Market analysis reveals For years UnitedHealth Group (UNH 0

Nevertheless, 38%) has normally been a reliable dividend stock

But an abysmal start to 2025 has wiped out many of the gains that investors have achieved in recent years, with its five-year return now in negative territory, in today's financial world

Furthermore, Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock

On the other hand, In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008

The big questions many investors are ly asking today are: Can it recover

However, Or is there more of a downfall to come for this once seemingly unstoppable stock

Additionally, Image source: Getty Images

Big declines aren't the norm for UnitedHealth The past few years haven't been all that great for UnitedHealth, but by and large, this has been a fairly strong stock to own

Nevertheless, This tells us that has typically outperformed the market

And outside of 2024 -- when it was down 4% -- the last time it a year in the red was (as noted) back in 2008, when the U (an important development)

Economy was in the midst of the Great Recession and the stock lost more than half of its value

Not only has UnitedHealth normally been a safe stock, it's also been a tremendous growth stock

Consider that if you invested $10,000 into its s at the end of 2003, then 20 years later your investment would have been worth $181,000

But if you hung on until now, that investment would have fallen to a value of $101,000

While that's still a good return, it spotlights just how significant the decline has been this year, for a stock that's typically known for being a solid long-term investment

Still, the past doesn't predict the future

Additionally, Why the company might face a tough road ahead The blem with UnitedHealth right now is that it's facing many challenges

Nevertheless, Medical costs are up, and there's a lot of uncertainty in healthcare as the federal government looks to cut costs

Furthermore, Meanwhile, the Department of Justice is reportedly looking into UnitedHealth's billing practices (an important development)

What the re reveals is danger is that the company may face financial repercussions and other headwinds, such as having to change its practices -- or at the very least, incurring higher-than-typical costs due to greater utilization rates, given the current landscape

Market analysis shows latter, however, may be a shorter-term trend, considering recent developments

Conversely, Either way, this is a known for consistently growing its operations, and that may not be a sure thing anymore

While UnitedHealth generated a healthy fit of more than $14. 4 billion on revenue of $400. 3 billion in 2024, investor concerns long-term growth appear to be weighing on the stock

Nevertheless, In May, the company susp its outlook for the year; it also announced a change in CEO, with Andrew Witty stepping down for personal reasons and former CEO Stephen Hemsley taking over, in today's financial world

Should you buy UnitedHealth stock today

While UnitedHealth stock has done well in previous years, that doesn't mean that it's a surefire bet to rebound soon, considering recent developments

However, Conversely, The good news is that it still has solid fundamentals

Since it's a key health insurer in the U. , I'd be hesitant to count it out in the long run

Moreover, This tells us that re's some near-term risk and even some long-term uncertainty how all the changes in the healthcare industry might pan out

But the stock is trading at levels it hasn't been at since 2020, and its valuation is just 12 times its trailing earnings, given current economic conditions

On the other hand, I think that gives it a good enough margin of safety at its current price, and that buying it today might ve to be a solid move

However, Nevertheless, As long as you're willing to be patient, this can be a good stock to buy and hold.